37 related articles for article (PubMed ID: 12384161)
1. Total, free, and complexed prostate-specific antigen levels among US men, 2007-2010.
Lacher DA; Hughes JP
Clin Chim Acta; 2015 Aug; 448():220-7. PubMed ID: 26093340
[TBL] [Abstract][Full Text] [Related]
2. [Exploration and validation of optimal cut-off values for tPSA and fPSA/tPSA screening of prostate cancer at different ages].
Liu XM; Duan HY; Zhang DQ; Chen C; Ji YT; Zhang YM; Feng ZW; Liu Y; Li JJ; Zhang Y; Li CY; Zhang YC; Yang L; Lyu ZY; Song FF; Song FJ; Huang YB
Zhonghua Zhong Liu Za Zhi; 2024 Apr; 46(4):354-364. PubMed ID: 38644271
[No Abstract] [Full Text] [Related]
3. Associations of serum vitamin A and carotenoid levels with markers of prostate cancer detection among US men.
Beydoun HA; Shroff MR; Mohan R; Beydoun MA
Cancer Causes Control; 2011 Nov; 22(11):1483-95. PubMed ID: 21800039
[TBL] [Abstract][Full Text] [Related]
4. A pilot study on percent free prostate specific antigen as an additional tool in prostate cancer screening.
Omar J; Jaafar Z; Abdullah MR
Malays J Med Sci; 2009 Jan; 16(1):44-7. PubMed ID: 22589648
[TBL] [Abstract][Full Text] [Related]
5. A systematic review of the diagnostic accuracy of prostate specific antigen.
Harvey P; Basuita A; Endersby D; Curtis B; Iacovidou A; Walker M
BMC Urol; 2009 Sep; 9():14. PubMed ID: 19744336
[TBL] [Abstract][Full Text] [Related]
6. Retracted: Exploration of the Value of Combined UA, IL-6, and fPSA/tPSA in the Diagnosis of Prostate Cancer.
Methods In Medicine CAM
Comput Math Methods Med; 2023; 2023():9839167. PubMed ID: 38094390
[TBL] [Abstract][Full Text] [Related]
7. Use of prostate-specific antigen (PSA) isoforms for the detection of prostate cancer in men with a PSA level of 2-10 ng/ml: systematic review and meta-analysis.
Roddam AW; Duffy MJ; Hamdy FC; Ward AM; Patnick J; Price CP; Rimmer J; Sturgeon C; White P; Allen NE;
Eur Urol; 2005 Sep; 48(3):386-99; discussion 398-9. PubMed ID: 15982797
[TBL] [Abstract][Full Text] [Related]
8. Prostate health index vs percent free prostate-specific antigen for prostate cancer detection in men with "gray" prostate-specific antigen levels at first biopsy: systematic review and meta-analysis.
Bruzzese D; Mazzarella C; Ferro M; PerdonĂ S; Chiodini P; Perruolo G; Terracciano D
Transl Res; 2014 Dec; 164(6):444-51. PubMed ID: 25035153
[TBL] [Abstract][Full Text] [Related]
9. Complexed prostate-specific antigen, complexed prostate-specific antigen density of total and transition zone, complexed/total prostate-specific antigen ratio, free-to-total prostate-specific antigen ratio, density of total and transition zone prostate-specific antigen: results of the prospective multicenter European trial.
Djavan B; Remzi M; Zlotta AR; Ravery V; Hammerer P; Reissigl A; Dobronski P; Kaisary A; Marberger M
Urology; 2002 Oct; 60(4 Suppl 1):4-9. PubMed ID: 12384156
[TBL] [Abstract][Full Text] [Related]
10. Predictors of prostate cancer on repeat prostatic biopsy in men with serum total prostate-specific antigen between 4.1 and 10 ng/mL.
Okegawa T; Kinjo M; Ohta M; Miura I; Horie S; Nutahara K; Higashihara E
Int J Urol; 2003 Apr; 10(4):201-6. PubMed ID: 12657099
[TBL] [Abstract][Full Text] [Related]
11. Volume indexes of total, free, and complexed prostate-specific antigen enhance prediction of extraprostatic disease extension in men with nonpalpable prostate cancer.
Naya Y; Fritsche HA; Cheli CD; Stamey TA; Bartsch G; Brawer MK; Childs S; Taneja SS; Lepor H; Partin AW; Sokoll LJ; Chan DW; Babaian RJ
Urology; 2003 Dec; 62(6):1058-62. PubMed ID: 14665355
[TBL] [Abstract][Full Text] [Related]
12. The significance of the free-to-complexed prostate-specific antigen (PSA) ratio in prostate cancer detection in patients with a PSA level of 4.1-10.0 ng/mL.
Okegawa T; Kinjo M; Watanabe K; Noda H; Kato M; Miyata A; Murata A; Yoshii M; Nutahara K; Higashihara E
BJU Int; 2000 Apr; 85(6):708-14. PubMed ID: 10759671
[TBL] [Abstract][Full Text] [Related]
13. Comparisons of the various combinations of free, complexed, and total prostate-specific antigen for the detection of prostate cancer.
Okegawa T; Noda H; Nutahara K; Higashihara E
Eur Urol; 2000 Oct; 38(4):380-7. PubMed ID: 11025374
[TBL] [Abstract][Full Text] [Related]
14. Can volume measurement of the prostate enhance the performance of complexed prostate-specific antigen?
Naya Y; Stamey TA; Cheli CD; Partin AW; Sokoll LJ; Chan DW; Brawer MK; Taneja SS; Lepor H; Bartsch G; Childs S; Fritsche HA; Babaian RJ
Urology; 2002 Oct; 60(4 Suppl 1):36-41. PubMed ID: 12384161
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]